Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA597197
Max Phase: Preclinical
Molecular Formula: C24H15N2NaO5S
Molecular Weight: 444.47
Molecule Type: Small molecule
Associated Items:
ID: ALA597197
Max Phase: Preclinical
Molecular Formula: C24H15N2NaO5S
Molecular Weight: 444.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1c(S(=O)(=O)[O-])cc(Nc2ccc3ccccc3c2)c2c1C(=O)c1ccccc1C2=O.[Na+]
Standard InChI: InChI=1S/C24H16N2O5S.Na/c25-22-19(32(29,30)31)12-18(26-15-10-9-13-5-1-2-6-14(13)11-15)20-21(22)24(28)17-8-4-3-7-16(17)23(20)27;/h1-12,26H,25H2,(H,29,30,31);/q;+1/p-1
Standard InChI Key: CNRIQWRNOWTUBN-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 444.47 | Molecular Weight (Monoisotopic): 444.0780 | AlogP: 4.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 126.56 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: -2.81 | CX Basic pKa: | CX LogP: 3.87 | CX LogD: 3.27 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.28 | Np Likeness Score: -0.30 |
1. Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J, Müller CE.. (2010) Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold., 53 (5): [PMID:20146483] [10.1021/jm901851t] |
2. Fiene A, Baqi Y, Malik EM, Newton P, Li W, Lee SY, Hartland EL, Müller CE.. (2016) Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila., 24 (18): [PMID:27522579] [10.1016/j.bmc.2016.07.027] |
3. Jeffrey JL,Lawson KV,Powers JP. (2020) Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39., 63 (22): [PMID:32786396] [10.1021/acs.jmedchem.0c01044] |
Source(1):